Cybin (FRA:R7E1) Accounts Payable & Accrued Expense : €5.56 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Cybin Accounts Payable & Accrued Expense?

Cybin's quarterly accounts payable & accrued expense increased from Jun. 2023 (€4.17 Mil) to Sep. 2023 (€6.40 Mil) but then declined from Sep. 2023 (€6.40 Mil) to Dec. 2023 (€5.56 Mil).

Cybin's annual accounts payable & accrued expense increased from Mar. 2021 (€3.28 Mil) to Mar. 2022 (€5.67 Mil) but then declined from Mar. 2022 (€5.67 Mil) to Mar. 2023 (€3.87 Mil).

Cybin Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cybin's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Accounts Payable & Accrued Expense Chart

Cybin Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

0.17

3.28

5.67

3.87

Cybin Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial										3.04	3.87	4.17	6.40	5.56

Cybin Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cybin (FRA:R7E1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E1) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CYBN:USA CYBN:Canada

Address

100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9

Website

https://www.cybin.com

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin (FRA:R7E1) Headlines

No Headlines